JUMPCODE Genomics
JumpCode provides technology for depleting unwanted nucleic acid. The CRISPRclean is a proprietary technology that utilizes the CRISPR/CAS system to deplete unwanted nucleic acid molecules from sequencing libraries. The applications of the technology include host organism depletion, ribosomal RNA depletion, repetitive sequence depletion, allele-specific depletion, and others. The patented CRISPRclean technology…
Funding snapshot
About
JumpCode provides technology for depleting unwanted nucleic acid. The CRISPRclean is a proprietary technology that utilizes the CRISPR/CAS system to deplete unwanted nucleic acid molecules from sequencing libraries. The applications of the technology include host organism depletion, ribosomal RNA depletion, repetitive sequence depletion, allele-specific depletion, and others. The patented CRISPRclean technology allows the researcher to remove unwanted regions. The company was founded in 2016 and headquartered in Carlsbad, United States. It has raised $38.7M in series b funding, with backing from Baird Capital, Arboretum Ventures, LYZZ Capital, HHS. The company operates in the Life Sciences - Genomics, Life Sciences - Life Sciences Platforms and Tools, HealthTech - Life Sciences Tech space. Provider of a technology for depleting unwanted nucleic acid.
Business model
Life Sciences Tech > Research & Development > Drug Informatics > Scientific Literature > Data Mining > Gene Analysis,
Genomics > Enabling Technologies > Kits and Reagents > Detection and Quantification,
Life Sciences Platforms and Tools > Research Reagents and Kits > Genomics > Nucleic Acid Synthesis > DNA
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.